Home › Triple-Negative Breast Cancer › New York › Greenburgh
Triple-Negative Breast Cancer clinical trials in Greenburgh, NY
7 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Greenburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi away
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RecruitingPhase 3
- White Plains Hospital Physician Associates, White Plains · 4 mi away
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale · 9 mi away
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RecruitingPhase 2/3
- White Plains Hospital, White Plains · 4 mi away
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
RecruitingPhase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi away
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Greenburgh
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer28 studies
- Acute Myeloid Leukemia18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Lung Cancer17 studies
- Multiple Myeloma13 studies
- Colorectal Cancer11 studies
- Metastatic Cancer11 studies
- Endometrial Cancer11 studies
- Bladder Cancer10 studies
- Lymphoma9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.